Asymptomatic coinheritance of heterozygous plasminogen deficiency and the factor V-Leiden mutation

被引:12
|
作者
McColl, MD
Tait, RC
Walker, ID
McCall, F
Conkie, JA
Perry, DJ
机构
[1] ROYAL INFIRM,DEPT HAEMATOL,GLASGOW G31 2ER,LANARK,SCOTLAND
[2] SO GEN HOSP NHS TRUST,GLASGOW,LANARK,SCOTLAND
[3] ROYAL FREE HOSP,SCH MED,LONDON,ENGLAND
关键词
plasminogen; factor V-Leiden mutation;
D O I
10.1097/00001721-199704000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deficiency of plasminogen has been postulated by some authors as a possible thrombophilic abnormality, though this remains controversial. We have previously identified a cohort of individuals with plasminogen deficiency from a study to determine plasminogen levels within the general population. All were asymptomatic for thrombosis at initial identification. We followed this cohort over a 5-year period, with no venous thrombotic events recorded, although one patient did suffer a myocardial infarction. One family was identified with asymptomatic coinheritance of both plasminogen deficiency and the factor V(Leiden)mutation. There was no apparent venous thrombotic risk conferred upon any of our cohort of individuals by inheritance of plasminogen deficiency, and, in addition, the combination of the factorV(Leiden) mutation with plasminogen deficiency which was observed in three individuals did not result in thrombotic events. However, the cohort is small and we cannot entirely exclude plasminogen deficiency as a possible mild thrombophilic defect.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 50 条
  • [31] Detection of the factor V-Leiden mutation - Development of a testing algorithm combining a coagulation assay and molecular diagnosis
    Wasserman, LM
    Edson, JR
    Key, NS
    Chibbar, R
    McGlennen, RC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 108 (04) : 427 - 433
  • [32] An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V-Leiden
    Bajzar, L
    Kalafatis, M
    Simioni, P
    Tracy, PB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) : 22949 - 22952
  • [33] Stroke in a neonate heterozygous for factor V Leiden
    Varelas, PN
    Sleight, BJ
    Rinder, HM
    Sze, G
    Ment, LR
    PEDIATRIC NEUROLOGY, 1998, 18 (03) : 262 - 264
  • [34] Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form
    Sveinsdotti, Signy V.
    Saemundsson, Ymir
    Isma, Nazim
    Gottsater, Anders
    Svensson, Peter J.
    THROMBOSIS RESEARCH, 2012, 130 (03) : 467 - 471
  • [35] Expression and characterization of recombinant factor V R506Q (factor V-LEIDEN)
    Wei, CJ
    QuinnAllen, MA
    Kane, WH
    BLOOD, 1995, 86 (10) : 801 - 801
  • [36] Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation
    Masaru Ishii
    Yoshinori Katada
    Rheumatology International, 2003, 23 : 44 - 46
  • [37] Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation
    Ishii, M
    Katada, Y
    RHEUMATOLOGY INTERNATIONAL, 2003, 23 (01) : 44 - 46
  • [38] Hereditary angioedema associated with heterozygous factor V Leiden mutation in a patient with purpura fulminans
    Celikel, S.
    Buyukasik, Y.
    Karakaya, G.
    Kalyoncu, A. F.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 142 (02) : 175 - 178
  • [39] Acute mesenteric ischemia in an African American patient with heterozygous factor V Leiden deficiency
    Barry, Hadiatou
    Ghani, Ali
    Smith, David Gary
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2019, 9 (03): : 255 - 257
  • [40] Two families with combined homozygous/heterozygous factor V Leiden mutation and heterozygous G20210A factor II variant
    Ruggeri, M
    Castaman, G
    Tosetto, A
    Rodeghiero, F
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (08) : 783 - 784